Maven Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,700
Closed -$1.02M 694
2025
Q2
$1.02M Sell
11,700
-296,600
-96% -$25.2M 0.02% 437
2025
Q1
$27.7M Buy
308,300
+287,700
+1,397% +$25.7M 0.85% 22
2024
Q4
$1.65M Sell
20,600
-124,300
-86% -$10.8M 0.04% 326
2024
Q3
$13M Buy
144,900
+96,500
+199% +$8.12M 0.25% 69
2024
Q2
$3.81M Buy
+48,400
New +$3.97M 0.08% 249
2023
Q4
Sell
-29,100
Closed -$2.28M 1091
2023
Q3
$2.28M Buy
29,100
+25,200
+646% +$2.11M 0.03% 366
2023
Q2
$344K Buy
+3,900
New +$336K 0.01% 707
2023
Q1
Sell
-6,300
Closed -$490K 1008
2022
Q4
$490K Buy
+6,300
New +$511K 0.01% 585
2022
Q1
Sell
-10,000
Closed -$1.03M 1057
2021
Q4
$1.03M Buy
+10,000
New +$1.16M 0.03% 336
2021
Q3
Sell
-7,800
Closed -$968K 1181
2021
Q2
$968K Buy
+7,800
New +$979K 0.04% 456
2020
Q3
Sell
-5,600
Closed -$514K 700
2020
Q2
$514K Buy
5,600
+600
+12% +$57.5K 0.04% 304
2020
Q1
$451K Buy
5,000
+1,200
+32% +$128K 0.05% 191
2019
Q4
$431K Buy
+3,800
New +$417K 0.04% 272

Other funds holding MDT

Maven Securities's MDT Position: Q2 2025 in Review

Maven Securities sold out of Medtronic (MDT) in Q2 2025, closing a stake of 5,462 shares — an estimated $463K sold.

Maven Securities first reported a position in MDT in Q1 2020 and held it in 10 quarters. The position peaked at $939K in Q3 2023. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Maven Securities reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Maven Securities sold 5,462 Medtronic shares in Q2 2025, an estimated $463K.
  • Maven Securities first reported a position in Medtronic in Q1 2020 and held it in 10 quarters.
  • Maven Securities's Medtronic position peaked at $939K in Q3 2023.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Maven Securities's 13F filing for Q2 2025, filed 14 Aug 2025.